title: [Childhood actinic lichen planus (6 cases)].
abstract: BACKGROUND
  Actinic lichen planus (ALP) is a chronic and benign disease that affects young people of the Middle East and Maghreb countries.
  
  
  OBJECTIVE
  To analyse clinical features and prognosis of ALP in children.
  
  
  METHODS
  A retrospective, descriptive study of cases observed in the department of dermatology of Sfax hospital over a period of 11 years (1995-2005).
  
  
  RESULTS
  Our patients were 5 boys and 1 girl. Mean age at diagnosis was 11 years. Onset was during the summer in 5 cases. The face was involved in 5 cases and the upper limb in 3 cases. The annular form was found in 5 cases, the pigmented melasma-like form in 1. Cheilitis was associated in 3 cases. Treatment consisted in photoprotection in all the patients. Antimalaria drugs were used in 4 patients and topical steroids in 2. Evolution was favourable in 5 cases. Disease relapsed in one child after treatment interruption.
  
  
  CONCLUSIONS
  ALP can be seen during childhood. Ultraviolet rays are involved in pathogenesis. The annular form is predominant. Treatment is based on sun protection associated with antimalarials or topical steroids.
authors.affiliation: Service de dermatologie, EPS Hédi-Chaker, route Elain-Km1, Sfax 3029, Tunisia. dammak1anis@yahoo.fr
authors.forename: A
authors.initials: A
authors.lastname: Dammak
authors.forename: A
authors.initials: A
authors.lastname: Masmoudi
authors.forename: S
authors.initials: S
authors.lastname: Boudaya
authors.forename: S
authors.initials: S
authors.lastname: Bouassida
authors.forename: S
authors.initials: S
authors.lastname: Marrekchi
authors.forename: H
authors.initials: H
authors.lastname: Turki
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D007231:Infant, Newborn; D007730:Kuwait / Q000453:epidemiology; D008010:Lichen Planus / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D008297:Male; D010787:Photosensitivity Disorders / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control / Q000628:therapy; D012008:Recurrence; D012189:Retrospective Studies; D012621:Seasons; D013473:Sunscreening Agents / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014416:Tunisia / Q000453:epidemiology
chemical_list: D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D013473:Sunscreening Agents; C011175:betamethasone-17,21-dipropionate; D001623:Betamethasone